| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
664 |
511 |
$753K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
9,010 |
8,299 |
$706K |
| 92134 |
|
20,347 |
18,881 |
$609K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,441 |
3,356 |
$331K |
| J9035 |
Injection, bevacizumab, 10 mg |
739 |
721 |
$74K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
87 |
87 |
$34K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
391 |
386 |
$28K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,119 |
1,079 |
$17K |
| 92201 |
|
757 |
719 |
$14K |
| Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg |
13 |
12 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
39 |
39 |
$4K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
13 |
13 |
$372.49 |